Your browser doesn't support javascript.
loading
Return-to-Work Guidelines and Programs for Post-Hematopoietic Cell Transplantation Survivors: An Initial Survey.
Salit, Rachel B; Lee, Stephanie J; Burns, Linda J; Shaw, Bronwen E; Majhail, Navneet S; Bhatt, Neel S; Wood, William A; Syrjala, Karen L.
Affiliation
  • Salit RB; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington. Electronic address: rsalit@fredhutch.org.
  • Lee SJ; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington.
  • Burns LJ; Transplant, Cellular Therapy, and Health Services Research, LLC, Stillwater, Minnesota.
  • Shaw BE; Center for International Blood and Marrow Transplant Research and Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Majhail NS; Blood and Marrow Transplant Program, Cleveland Clinic, Cleveland Ohio.
  • Bhatt NS; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington.
  • Wood WA; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
  • Syrjala KL; Fred Hutchinson Cancer Research Center, Seattle, Washington; University of Washington School of Medicine, Seattle, Washington.
Biol Blood Marrow Transplant ; 26(8): 1520-1526, 2020 08.
Article in En | MEDLINE | ID: mdl-32360563
Hematopoietic cell transplantation (HCT) requires absence from work, with potential consequences of unemployment and early retirement. Risk factors for failure to return to work (RTW) following HCT have been reported, but there is little information about how transplant centers facilitate the RTW transition for their post-HCT patients. In the present study, we aimed to determine (1) whether transplant centers have guidelines for RTW post-HCT and the consistency of these guidelines and (2) whether centers have RTW programs for their patients, and the characteristics of these programs. We surveyed representatives from 150 adult transplant centers regarding their RTW guidelines and RTW programs. Centers were selected if they performed at least 50 HCTs (autologous [auto] and/or allogeneic [allo]) annually. The online survey contained 32 open-ended and closed-ended questions and 3 questions each eliciting respondents' demographic and transplant centers information. We received completed surveys from 45 centers (30% response rate). Forty-four percent of centers reported having RTW guidelines. All centers recommend RTW at 6 months or less after HCT for their auto-HCT recipients; recommendations for allo-HCT recipients ranged from 4 months to >1 year after HCT having jobs involving interactions with children, sick people, and animals was considered a reason to delay RTW by most centers. Although 87% of centers endorsed that RTW is a problem for post-HCT recipients, only 36% reported having an RTW program for their patients. The majority validated that RTW programs would be either somewhat helpful (36%) or very helpful (51%) for their patients. The majority of responding HCT centers believe that RTW is a problem for patients after HCT; however, consistent guidelines and RTW programs are lacking. With increasing numbers of HCT survivors, efforts to create standardized guidelines and to develop RTW programs are needed.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Return to Work Type of study: Guideline / Qualitative_research / Risk_factors_studies Limits: Adult / Child / Humans Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Return to Work Type of study: Guideline / Qualitative_research / Risk_factors_studies Limits: Adult / Child / Humans Language: En Year: 2020 Type: Article